Risks of female genital tract related cancers (gynecological cancers) or breast cancer in women with and without chronic kidney disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risks of female genital tract related cancers (gynecological cancers) or breast cancer in women with and without chronic kidney disease

Published:2018-03 Issue:12 Volume:97 Page:e0157
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Chang Wen-Hsun,Horng Huann-Cheng,Yeh Chang-Ching,Guo Chao-Yu,Chou Yiing-Jeng,Huang Nicole,Huang Hsin-Yi,Chen Yi-Jen,Lee Wen-Ling,Wang Peng-Hui

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference68 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Cancer incidence in physicians: a Taiwan national population-based cohort study;Lee;Medicine (Baltimore,2015

3. Outstanding female cancer research paper awards of the 2015 Taiwan Association of Obstetrics and Gynecology and Hsu Chien-Tien Cancer Foundation;Wang;Taiwan J Obstet Gynecol,2016

4. Outstanding female cancer research paper awards of the 2016 Taiwanese Association of Obstetrics and Gynecology and Hsu Chien Cancer Foundation;Wang;Taiwan J Obstet Gynecol,2017

5. Outstanding female cancer research paper awards of the Taiwanese Association of Obstetrics and Gynecology;Wang;Taiwan J Obstet Gynecol,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aberrant sialylation in ovarian cancers;Journal of the Chinese Medical Association;2020-04

2. Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer;International Journal of Environmental Research and Public Health;2020-03-26

3. Weekly Dose-Dense Paclitaxel and Triweekly Low-Dose Cisplatin: A Well-Tolerated and Effective Chemotherapeutic Regimen for First-Line Treatment of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer;International Journal of Environmental Research and Public Health;2019-11-29

4. The association of the decline in glomerular filtration rate with aggressive endometrial cancers;International Urology and Nephrology;2019-11-01

5. CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway;OncoTargets and Therapy;2018-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3